Eighty years later, academic and cultural institutions the world over are deciding whether to reject the Sackler brothers’ children — not because of their religion but because of their actions.
Despite a recently-agreed $7.4 billion settlement, the Sackler family has yet to fully account for its role in America's ...
The family has remained virtually untouched since then. The three original Sackler brothers, all physicians, bought Purdue in 1952 and developed OxyContin in 1996. Six Sackler members sat on the ...
This month’s KELOLAND Living Book Club selection examines the history of the Sackler family, including the founding of Purdue Pharma, its role in the marketing of pharmaceuticals, and the family ...
Purdue Pharma, the manufacturers of OxyContin, and members of the family that own the company, will pay billions to victims of the opioid crisis, as well as state and local governments.Jan. 23, 2025 ...
The Justice Department argued that shielding the… OxyContin maker Purdue Pharma can start its transformation under a bankruptcy agreement that allows the members of the wealthy Sackler family ...
Jan 13 (Reuters) - The Sackler family owners of Purdue Pharma are offering to increase their financial contribution to a bankruptcy settlement of opioid lawsuits, while agreeing to some exposure ...
The money is part of a pending $7.4 billion settlement reached with members of the Sackler family and their company, Purdue Pharma, Inc., that still needs court approval. Pennsylvania and 14 other ...
Purdue flourished under brothers Mortimer and Raymond Sackler, who died in 2010 and 2017, respectively. The family reaped ...
10/10 The Sackler family's reputation comes under intense scrutiny around the world.
The University of Oxford is to remove the Sackler name from its buildings over the family's association with the opioid crisis in the US. The Sackler Library and galleries and staff posts at the ...
Book of the Week. Patrick Radden Keefe investigates how the Sackler family acquired their phenomenal wealth, and their role in the America's opioid crisis. Kyle Soller reads.